Dimerix Limited (ASX:DXB) Secures Major Licensing Deal in Japan and FDA Endorsement for DMX-200
Dimerix Limited (ASX:DXB) secures a ¥10.5 billion licensing deal in Japan and receives FDA endorsement for its DMX-200 therapy.
Dimerix Limited (ASX:DXB) secures a ¥10.5 billion licensing deal in Japan and receives FDA endorsement for its DMX-200 therapy.
Australian Gold and Copper Ltd (ASX:AGC) accelerates its Achilles exploration program, reporting strong geochemical anomalies and notable drilling results in 2025.
Cobre Limited (ASX:CBE) secures a major earn-in agreement with BHP and delivers encouraging exploration results in Botswana and Australia.
BPH Global Limited (ASX:BP8) releases Q1 2025 report, secures $609K funding, and advances Indonesian seaweed projects.
Ionic Rare Earths (ASX: IXR) reports significant progress in magnet recycling and heavy rare earth projects, reducing CO₂ emissions.
Aurora Labs (ASX:A3D) completes development of the AU4 micro gas turbine, advancing production and defence sector engagements.
NOVONIX Limited (ASX:NVX) finalizes a $5 million land purchase in Chattanooga, expanding production capacity and creating up to 500 jobs.
EMVision Medical Devices Limited (ASX:EMV) has commenced pivotal clinical trials for its emu™ brain scanner and announced successful device testing and robust cash reserves.
GreenTech Metals (ASX:GRE) reports significant copper drill results and a joint venture with Artemis to expand lithium projects in West Pilbara.
Patronus Resources (ASX: PTN) reports increased mineral resources and strategic investments in Q1 2025.